Eli Lilly in advanced talks to acquire Kelonia Therapeutics for over $2 billion, WSJ says
April 19 (Reuters) - Eli Lilly is in advanced talks to acquire Kelonia Therapeutics for more than $2 billion, the Wall Street Journal reported on Sunday.
Reuters could not immediately verify the report.
(Reporting by Mihika Sharma in Bengaluru; Editing by Lisa Shumaker)
Brought... Read More.


